The recent disruptions in global distribution have highlighted the necessity of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes nations to significant vulnerabilities, including transportation delays, expense fluctuations, and even political concerns. Moving towards domestic production of Ivermectin offer